Methylphenidate STADA Hart hylki með breyttan losunarhraða 20 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate stada hart hylki með breyttan losunarhraða 20 mg

stada arzneimittel ag - methylphenidatum hýdróklóríð; methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 20 mg

Methylphenidate STADA Hart hylki með breyttan losunarhraða 40 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate stada hart hylki með breyttan losunarhraða 40 mg

stada arzneimittel ag - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 40 mg

Methylphenidate STADA Hart hylki með breyttan losunarhraða 60 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

methylphenidate stada hart hylki með breyttan losunarhraða 60 mg

stada arzneimittel ag - methylphenidatum hýdróklóríð - hart hylki með breyttan losunarhraða - 60 mg

Ceprotin الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

ceprotin

takeda manufacturing austria ag - manna prótein c - purpura fulminans; protein c deficiency - blóðþurrðandi lyf - ceprotin is indicated for prophylaxis and treatment of  purpura fulminans  coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.

Fosrenol Tuggutafla 750 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

fosrenol tuggutafla 750 mg

takeda pharmaceuticals international ag ireland branch - lanthanum karbónat - tuggutafla - 750 mg

Fosrenol Tuggutafla 500 mg أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

fosrenol tuggutafla 500 mg

takeda pharmaceuticals international ag ireland branch - lanthanum karbónat - tuggutafla - 500 mg